Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Early Percutaneous Catheter Drainage of Sterile Pancreatic Fluid Collections in Severe Acute Pancreatitis (EPCDSAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03185806
Recruitment Status : Recruiting
First Posted : June 14, 2017
Last Update Posted : October 9, 2017
Sponsor:
Information provided by (Responsible Party):
Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary:
The acute peripancreatic fluid collections (AFPCs) is the most common complication in severe acute pancreatitis (SAP). There are controversies on optimal timing for drainage of APFCs in SAP. The early-stage percutaneous catheter drainage (PCD) of sterile peripancreatic fluid collections is questioned as a result of the major cause of secondary infection. The aim of the present randomized controlled trial is to compare the outcomes in terms of mortality, secondary infection of peripancreatic collections, organ failure, length of hospital/ICU stay and inflammatory biomarkers between the early-stage PCD of sterile AFPCs and conservative therapy.

Condition or disease Intervention/treatment Phase
Severe Acute Pancreatitis Device: Puncture and drainage Not Applicable

Detailed Description:

The AFPCs is the most common complication in SAP and debate continues regarding the appropriate timing for drainage of sterile APFCs in SAP patients. Some researchers have reported that the massive amounts of inflammatory mediators in the peripancreatic fluid may aggravate the inflammatory reaction and contribute to organ failure (OF) when liberated into the bloodstream by peritoneal absorption. Additionally, bacterial colonization of APFCs may lead to peritoneal abscess formation and sepsis. In a recent study, Wang et al. revealed that early-stage PCD effectively attenuated the peritoneal pressure and decreased the incidence of infection and OF. Finally, APFCs and secondary infection are considered major causes of alimentary tract hemorrhage. Based on these factors, prompt drainage of APFCs seems reasonable for patients in early SAP. In addition, unlike the original 1992 Atlanta classification guidelines (1992-AC), the revision of the 1992-AC by international consensus in 2012 (2012-RAC) highlighted the significance of persistent OF in the classification of SAP. To be exact, those patients diagnosed with SAP according to the 1992-AC without OF or with transient OF were reclassified as having mild AP (MAP) or moderate severity AP (MSAP) by the 2012-RAC. Therefore, many studies have reported changes in the treatment of SAP in the early stages since the 2012-RAC were published. We have retrospectively analyzed 361 patients with AP and found that the early-stage PCD of sterile APFCs in SAP-2012RAC patients can significantly reduce the mortality rate. However, on the contrary, the mainstream viewpoint holds that drainage is not necessary in the absence of infection of the peripancreatic fluid as the fluid can be absorbed completely and sterile PCD may increase the risk of iatrogenic infection. However, these mainstream views aimed at 1992-AC's SAP patients, which actually contain 2012-RAC's SAP and MSAP. Therefore, we hypothesized that the introduction of new AP severity classification methods may alter the indications for early aseptic drainage of AFPCs.

Does early PCD of sterile APFCs benefits patients or increases the secondary infection rate? In view of these problems, we plan to design a randomized controlled trial to compare the outcomes in terms of mortality, secondary infection of peripancreatic collections, organ failure, length of hospital/ICU stay and inflammatory biomarkers between the early-stage PCD of sterile AFPCs and conservative therapy. The aim of this prospective study is to investigate whether early PCD of sterile AFPCs can be used to SAP patients with AFPCs at early stage.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized, Multicenter and Prospective Trial of Early Percutaneous Catheter Drainage of Sterile Pancreatic Fluid Collections in Severe Acute Pancreatitis
Estimated Study Start Date : October 6, 2017
Estimated Primary Completion Date : October 6, 2020
Estimated Study Completion Date : October 6, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Puncture and Drainage
The enrolled SAP patients are administered puncture and drainage use 8-F or 10-F pigtail tube under guidance of B ultrasound or CT scan.
Device: Puncture and drainage
The enrolled SAP patients are punctured under guidance of B ultrasound or CT scan, and prolonged drained by 8-F or 10-F pigtail tube

No Intervention: Conservative therapy
The enrolled SAP patients are administered conservative therapy and without puncture and prolonged drainage.



Primary Outcome Measures :
  1. Mortality [ Time Frame: From date of admisstion until the date of in-hospital death or death within two weeks after discharging, whichever came first, assessed up to 1 year. ]
    Determine and compare the death rates in patients who are administered drainage and conservative therapy: Assess the total number of cases of death in each group (Treatment and control)


Secondary Outcome Measures :
  1. Secondary infection of peripancreatic collections [ Time Frame: From date of admisstion until the secondary infection of peripancreatic collections occurred, assessed up to 100 days ]
    Compare the secondary infection rates of peripancreatic collections in patients who are administered drainage and conservative therapy: Assess the total numbers of cases of secondary infection of peripancreatic collections in each group (Treatment and control)

  2. New set of organ failure [ Time Frame: From date of admisstion until new set of organ failure occurred, assessed up to 100 days ]
    Compare the new set of organ failure rates in patients who are administered drainage and conservative therapy: Assess the total numbers of cases of new set of organ failure in each group (Treatment and control)

  3. Length of hospital/ICU stay [ Time Frame: From date of admisstion until the patient is transfered to normal ward or discharge, whichever came first, assessed up to 1 year. ]
    Compare the length of hospital/ICU stay in patients who are administered drainage and conservative therapy

  4. Aggressive procedures: open necrosectomy and minimally invasive retroperitoneal necrosectomy [ Time Frame: From date of admisstion until the patient receives aggressive procedures, assessed up to 100 days ]
    Compare the aggressive procedures rates in patients who are administered drainage and conservative therapy.

  5. Abdominal hemorrhage [ Time Frame: From date of admisstion until the abdominal hemorrhage occurred, assessed up to 100 days ]
    Compare the abdominal hemorrhage rates in patients who are administered drainage and conservative therapy.

  6. Digestive tract fistula [ Time Frame: From date of admisstion until the Digestive tract fistula occurred, assessed up to 100 days ]
    Compare the digestive tract fistula rates in patients who are administered drainage and conservative therapy.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age of 18 years to 70 years; and
  2. Pain characteristic of pancreatitis; and
  3. Elevated serum lipase or amylase (≥3-fold upper normal range); and
  4. Persistent organ failure >48 hours; and
  5. Organ dysfunction occurred within 7 days after onset of pain; and
  6. Presentation with a width of ≥2cm of APFCs in the peripheral tissues of the pancreas, the cyst of lesser omentum , or the paracolic sulci on CT image.

Exclusion Criteria:

  1. History diseases of chronic organ dysfunction; or
  2. Traumatic pancreatitis; or
  3. Post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis; or
  4. Severe coagulopathy (INR>2); or
  5. Severe thrombocytopenia (PLT≤50×109/L); or
  6. No suitable route for puncturing; or
  7. Pregnancy; or
  8. Absent of informed consent from patient or representative.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03185806


Contacts
Layout table for location contacts
Contact: Tingbo Liang, MD,PhD 86-571-87315006 liangtingbo@zj.edu.cn
Contact: Yun Zhang, MD 86-571-87315006 bigzyun@hotmail.com

Locations
Layout table for location information
China, Zhejiang
The second affiliated hospital of Zhejiang University Recruiting
Hangzhou, Zhejiang, China
Contact: Yun Zhang, MD         
Sponsors and Collaborators
Second Affiliated Hospital, School of Medicine, Zhejiang University

Layout table for additonal information
Responsible Party: Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier: NCT03185806     History of Changes
Other Study ID Numbers: SAHZhejiangU-EPCDSAP
First Posted: June 14, 2017    Key Record Dates
Last Update Posted: October 9, 2017
Last Verified: May 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Second Affiliated Hospital, School of Medicine, Zhejiang University:
severe acute pancreatitis
sterile acute peripancreatic fluid collections
percutaneous catheter drainage
Additional relevant MeSH terms:
Layout table for MeSH terms
Pancreatitis
Infertility
Pancreatic Diseases
Digestive System Diseases
Genital Diseases, Male
Genital Diseases, Female